Cooley, Linklaters Steer $69M Biotech IPO, Private Placement
French biotech Innate Pharma said Thursday it raised a total of $68.8 million in a downsized U.S. initial public offering and a European private placement steered by Cooley LLP and Linklaters...To view the full article, register now.
Already a subscriber? Click here to view full article